VMP 41761211000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Dasatinib 50mg tablets
BNF code 0801050ANAAABAB
Virtual Therapeutic Moiety Dasatinib
Date identifier became valid 9 May 2023
Previous product identifier 424254006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Dasatinib monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 423658008
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Dasatinib 50mg tablets (A A H Pharmaceuticals Ltd)
Dasatinib 50mg tablets (Sandoz Ltd)
Dasatinib 50mg tablets (Teva UK Ltd)
Dasatinib 50mg tablets (Viatris UK Healthcare Ltd)
Dasatinib 50mg tablets (Zentiva Pharma UK Ltd)
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
Virtual Medicinal Product Packs
Dasatinib 50mg tablets 56 tablet
Dasatinib 50mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.

Feedback